Also trades as: RCE.AX (ASX) · $vol 0M
RECEF OTC
Recce Pharmaceuticals Ltd
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: -63.3%
$0.22
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$9M
-31.4% ▼
5Y CAGR: -17.0%
Total Liabilities
$25M
+63.0% ▲
5Y CAGR: +84.6%
Shareholders Equity
-$17M
-447.2% ▼
Cash & Investments
$3M
-74.2% ▼
5Y CAGR: -33.6%
Total Debt
$10M
-3.2% ▼
5Y CAGR: +141.5%
Net Debt
$8M
+2321.8% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $12M | $2M | $4M | $10M | $3M |
| Short-Term Investments | $0 | $0 | $0 | $237K | $0 |
| Cash & ST Investments | $12M | $2M | $4M | $10M | $3M |
| Net Receivables | $583K | $91K | $159K | $435K | $4M |
| Inventory | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $20K | $160K | $340K | $208K | $23K |
| Total Current Assets | $12M | $2M | $5M | $11M | $7M |
| Property, Plant & Equip. | $439K | $608K | $1M | $1M | $1M |
| Goodwill & Intangibles | $33 | $20 | $0 | $7 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Other Non-Current Assets | -$34 | -$21 | $0 | -$7 | $0 |
| Total Non-Current Assets | $439K | $608K | $1M | $1M | $1M |
| Total Assets | $13M | $3M | $6M | $12M | $9M |
| — Liabilities — | |||||
| Accounts Payable | $481K | $949K | $4M | $2M | $8M |
| Short-Term Debt | $0 | $0 | $0 | $2M | $2M |
| Deferred Revenue | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $2M | $3M | $10M | $1M | $5M |
| Total Current Liabilities | $2M | $5M | $15M | $6M | $16M |
| Long-Term Debt | $0 | $0 | $0 | $9M | $8M |
| Other Non-Current Liab. | $115K | $192K | $237K | $319K | $193K |
| Total Non-Current Liabilities | $115K | $295K | $824K | $9M | $9M |
| Total Liabilities | $3M | $5M | $16M | $15M | $25M |
| — Equity — | |||||
| Common Stock | $44M | $44M | $55M | $82M | $82M |
| Retained Earnings | -$42M | -$56M | -$70M | -$92M | -$101M |
| Accumulated OCI | $9M | $9M | $6M | $7M | $3M |
| Total Stockholders Equity | $10M | -$3M | -$10M | -$3M | -$17M |
| Total Liabilities & Equity | $13M | $3M | $6M | $12M | $9M |
| — Key Metrics — | |||||
| Total Debt | $75K | $251K | $811K | $11M | $10M |
| Net Debt | -$12M | -$1M | -$4M | $319K | $8M |
| Total Investments | $0 | $0 | $0 | $237K | $0 |